SOX30 specially prevents Wnt-signaling to suppress metastasis and improve prognosis of lung adenocarcinoma patients

Table 1 Correlation of SOX30 expression with clinicopathologic features in ADC patients (n = 275)

Clinical feature	Total	SOX30 expression		P value
Clinical feature	Total	High (n = 94)	Low (n = 181)	P value
Age (years)
≤ 60	151	56	95	0.328
> 60	121	38	83
Clinical stage
I	116	42	74	0.023
II	39	14	25
III	56	13	43
IV	16	1	15
Tumor size
T1–2	213	76	137	0.012
T3–4	31	4	27
Lymph node status
N0	128	45	83	0.160
N1–3	95	25	70
Metastasis
M0	230	78	152	0.022
M1	16	1	15
Gender
Male	152	52	100	0.991
Female	123	42	81
Histological grade
1	28	7	21	0.486
2	108	40	68
3	70	25	45
Tumor diameter
≤ 4 cm	196	72	124	0.082
> 4 cm	71	18	53
Location
Left	125	46	79	0.426
Right	149	48	101

The p values were measured with Pearson chi-square tests
The tumor clinical stage, tumor status, lymph node status and metastasis were classified according to the international system
All statistical tests are two sided
The entries in boldface indicate statistically significant

ISSN: 1465-993X